Informations générales
  • Catégorie de maladie Autre (BASEC)
  • État du recrutement recrutement pas encore commencé (BASEC/ICTRP)
  • Lieu de l’étude
    Bâle
    (BASEC)
  • Responsable de l'étude PD Dr. med. Margret Hund-Georgiadis m.hund@rehab.ch (BASEC)
  • Source(s) de données BASEC: Importé de 05.02.2026 ICTRP: N/A
  • Date de mise à jour 05.02.2026 10:15
HumRes67789 | SNCTP000006785 | BASEC2025-02393

Electrical Brain Stimulation at Home with the FLOW Device for the Treatment of Fatigue in Individuals with Post-COVID Syndrome.

  • Catégorie de maladie Autre (BASEC)
  • État du recrutement recrutement pas encore commencé (BASEC/ICTRP)
  • Lieu de l’étude
    Bâle
    (BASEC)
  • Responsable de l'étude PD Dr. med. Margret Hund-Georgiadis m.hund@rehab.ch (BASEC)
  • Source(s) de données BASEC: Importé de 05.02.2026 ICTRP: N/A
  • Date de mise à jour 05.02.2026 10:15

Résumé de l'étude

Your participation in the study includes a total of 5 visits to the clinic. 1. Pre-examination During the pre-examination (first appointment), you will be informed about the study and it will be checked whether you are eligible to participate. Within 2 weeks after the first appointment, the so-called screening (second appointment) follows: here, the study participants are first randomly assigned to one of the 2 groups (Group A or Group B). For the clear and understandable presentation of the study visits, the patient information is based solely on the sequence of visits as planned for Group A. This allows for a uniform and comprehensible description of the study process, as the visits for both groups are the same in content and only differ in the order of interventions. After the assignment, various tests and questionnaires will be conducted. 2. Treatment phase (for four weeks) Then, the first phase of the study begins. Group A starts with the four-week stimulation at home. This takes place five days a week, once daily for 30 minutes. To support the effect of the stimulation, it is recommended to engage in a light activity during the session (e.g., listening to music, watching TV, doing puzzles). During this phase, you will fill out a diary daily (duration: max. 5 minutes). 3. Tests after the treatment phase After the treatment phase, we will repeat the tests and questionnaires that were also conducted at the beginning of the study. 4. Usual treatments In the next four weeks, there will be no further treatment or tests. During this time, you will continue your usual therapies. 5. Tests and questionnaires after the four weeks without treatment. 6. Final examination The tests and questionnaires will be repeated after four weeks.

(BASEC)

Intervention étudiée

The planned intervention involves the application of low-intensity electrical brain stimulation (called transcranial direct current stimulation = tDCS) using the FLOW device. This involves anodic stimulation of the left dorsolateral prefrontal cortex (DLPFC) with a current strength of 2 milliamperes (mA). A total of 20 stimulation sessions are planned, which will take place over a period of four weeks. The self-administered stimulation occurs 5 days a week, each for 30 minutes. The stimulation is carried out independently by the participants in their home environment. Before the intervention begins, all participants receive a detailed instruction on how to operate the device, including written instructions and, if necessary, technical support from the study team. The self-application is designed to be safe, standardized, and practical for the participants.

(BASEC)

Maladie en cours d'investigation

Post-COVID Syndrome

(BASEC)

Critères de participation
- Adult individuals ≥ 18 years old at the time of obtaining informed consent. - Post-COVID diagnosis (after acute infection, maximum 24 months old). - Fatigue Scale (FSS): A total score of ≥5 indicating significant fatigue. (BASEC)

Critères d'exclusion
- Other diagnosed conditions associated with fatigue (e.g., pre-existing Chronic Fatigue Syndrome, Multiple Sclerosis). - Presence of a brain pacemaker or intracerebral metal implants (electrodes, plates, clips, VP-shunt, cochlear implant). - Pregnant or breastfeeding women. (BASEC)

Lieu de l’étude

Bâle

(BASEC)

non disponible

Sponsor

REHAB Basel

(BASEC)

Contact pour plus d'informations sur l'étude

Personne de contact en Suisse

PD Dr. med. Margret Hund-Georgiadis

+41 61 325 00 06

m.hund@rehab.ch

REHAB Basel, Klinik für Neurorehabilitation und Paraplegiologie

(BASEC)

Informations scientifiques

non disponible

Nom du comité d'éthique approbateur (pour les études multicentriques, uniquement le comité principal)

Ethikkommission Nordwest- und Zentralschweiz EKNZ

(BASEC)

Date d'approbation du comité d'éthique

05.02.2026

(BASEC)


Identifiant de l'essai ICTRP
non disponible

Titre officiel (approuvé par le comité d'éthique)
Heimbasierte transkranielle Gleichstromstimulation mittels FLOW- Geräts zur Behandlung von Fatigue bei Personen mit Post-COVID- Syndrom. (BASEC)

Titre académique
non disponible

Titre public
non disponible

Maladie en cours d'investigation
non disponible

Intervention étudiée
non disponible

Type d'essai
non disponible

Plan de l'étude
non disponible

Critères d'inclusion/exclusion
non disponible

non disponible

Critères d'évaluation principaux et secondaires
non disponible

non disponible

Date d'enregistrement
non disponible

Inclusion du premier participant
non disponible

Sponsors secondaires
non disponible

Contacts supplémentaires
non disponible

ID secondaires
non disponible

Résultats-Données individuelles des participants
non disponible

Informations complémentaires sur l'essai
non disponible

Résultats de l'essai

Résumé des résultats

non disponible

Lien vers les résultats dans le registre primaire

non disponible